TXN vs ZNTL · P/E 52, rev $10.29B vs $257.7M cap
Texas Instruments Incorporated (TXN) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ. It is led by Haviv Ilan.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
TXN currently screens at market cap $274.74B and trailing P/E 51.7. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the TXN and ZNTL stock pages for the full models.
Not investment advice.